Shilpa Medicare Limited
SHILPAMED.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$199.83B
Close$
$-236.06
124.2% downside
Current Fair Value
124.2% downsideOvervalued by 124.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $199.83 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.50 (0.11%) |
| Earnings per Share | $12.44 |
| Beta | 0.29 |
| Outstanding Shares | 195,503,876 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 67.22 |
|---|---|
| PEG | 58.37 |
| Price to Sales | 11.32 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$4.03
Average shareholder expectationRevenue Estimate
$4.60 B
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$3.87
Average shareholder expectationRevenue Estimate
$4.73 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shilpa Medicare Limited
1,132 employees
CEO: Vishnukanth Chaturbhuj Bhutada Shilpa Medicare Limited, including its associated entities, specializes in the production and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and finished drug formulations, serving markets across...